Your browser doesn't support javascript.
loading
Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.
Wu, Junduo; Liang, Wenzhao; Tian, Yueli; Ma, Fuzhe; Huang, Wenlin; Jia, Ye; Jiang, Ziping; Wu, Hao.
Afiliação
  • Wu J; Department of Cardiology, The Second Hospital of Jilin University, Changchun, Jilin, China.
  • Liang W; Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, Heilongjiang, China.
  • Tian Y; Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
  • Ma F; Occupational and Environmental Medicine Center, Linköping University, Linköping, Sweden.
  • Huang W; Department of Gastroenteric Medicine, The Second Hospital of Jilin University, Changchun, Jilin, China.
  • Jia Y; Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Jiang Z; School of Science and Technology, Georgia Gwinnett College, Lawrenceville, Georgia.
  • Wu H; Department of Diabetes Complications and Metabolism, Diabetes Metabolism Research Institute, Beckman Research Institute of City of Hope, Duarte, California.
J Cell Mol Med ; 23(5): 3538-3548, 2019 05.
Article em En | MEDLINE | ID: mdl-30793480

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endotélio Vascular / Proteína Supressora de Tumor p53 / MicroRNAs / Diabetes Mellitus Experimental / Sirtuína 1 Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endotélio Vascular / Proteína Supressora de Tumor p53 / MicroRNAs / Diabetes Mellitus Experimental / Sirtuína 1 Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article